NewsRoom Articles - Page 178 of 256

WednesdaySep 26, 2018 9:00 am

CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp

CBDWire Editorial Coverage: With Canada legalizing cannabis nationwide in October and the 2018 U.S. Farm Bill completely removing hemp from the DEA’s controlled substances list, the stage has been set for an explosion of products ranging from functional foods and supplements to CBD-based (cannabidiol) biopharma indications. U.S. farm bill legalizing hemp could make CBD an open-pit gold mine. List of demonstrable CBD health benefits growing daily. CBD growth may outpace entire cannabis market combined. Even before the landmark inclusion of the Hemp Farming Act of 2018 in this year’s Farm Bill, plant-based nutrition experts at leading omni-direct lifestyle company Youngevity…

TuesdaySep 25, 2018 9:00 am

Something for Everyone: Baby Boomers Signify Shift in the Cannabis Market

CBDWire Editorial Coverage: Since they came onto the scene after World War II, baby boomers have heavily impacted the world around them, and their influence is being felt now in the emerging cannabis market. A recent survey has shown a significant increase in cannabinoid-derived product consumption in the United States, most notably among baby boomers. With a combination of disposable income, health issues and liberal attitudes towards drugs, baby boomers represent a natural market for cannabis companies. This trend also signifies wider growth and diversification of products and customers in the industry. Marijuana Company of America, Inc. (OTC: MCOA) (MCOA…

TuesdaySep 25, 2018 9:00 am

Hydroponic Hardware Key to Tapping Long-Term Profits of Burgeoning Cannabis Market

CBDWire Editorial Coverage: The North American cannabis market continues to accelerate as Canada rockets towards the October 17 deadline for the nationwide legalization of recreational marijuana. Hydroponic market trying to keep up with booming cannabis market set to exceed $25 billion by 2021. Continued expansion of cannabis cultivation and demand for controllable production parameters are a boon to hydroponics industry. Healthcare sector increasing demand for CBD from sources such as industrial hemp. Regulatory reform throughout North America and Europe driving change in overall space. The milestone legislation appears set to open the door wider for companies pursuing a position in…

MondaySep 24, 2018 2:06 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) “Gets It Right” in Cannabinoid Extraction

Sol-gel nose-to-brain system offers superior drug delivery New extraction protocol makes accurate and precise quantification of cannabinoids possible Establishment of cannabis division to commercialize research developments A recent release from PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) shows that, in cannabinoid extraction technology, the health sciences company is getting it right. The company announced that, during its soluble gel drug delivery research and development program – the Sol-gel Program – it had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method – the Extraction Protocol – for the accurate…

MondaySep 24, 2018 12:57 pm

Inaugural Cannabis Strategic Ventures, Inc. (NUGS) and True Promise Beauty CBD-Based Product Line Set to Be Launched by Year-End 2018

The first products resulting from the joint venture between Cannabis Strategic Ventures and True Promise Beauty are scheduled to be launched by the end of 2018 The CBD-based luxury cosmetics line will feature face, skin and hair care products These products feature innovative formulations that aren’t currently available; the two companies hope to achieve strategic success in a constantly expanding luxury skin care market Cannabis Strategic Ventures, Inc. (OTC: NUGS) and True Promise Beauty have announced the development of LYXR – a new line of cannabidiol (CBD)-based luxury skin and hair care products. The entire LYXR line will be developed…

FridaySep 21, 2018 1:21 pm

Tilray, Inc.’s (NASDAQ: TLRY) Status as Global Pioneer in Cannabis Production, Distribution Reinforced by Earnings, Growth

First medical cannabis producer in North America to meet rigorous standards of GMP certification, supplying cannabis flower and extracts Canadian federally-licensed cannabis cultivator, processor and distributor Q2 2018 revenue increased to $9.7 million, up 95.2 percent over second quarter of 2017 Multinational distribution network makes Tilray medical cannabis available to patients in 11 countries on five continents Raised $163.6 million in a successful IPO in July 2018 and $55 million from leading institutional investors prior to IPO Agreements signed to supply medical cannabis via Canadian pharmacies and recreational cannabis to adult-use consumers in seven Canadian provinces and territories Received U.S.…

FridaySep 21, 2018 12:49 pm

ChineseInvestors.com, Inc. (CIIX) Expands North American Footprint for Chinese-Language News, CBD Product Market

ChineseInvestors.com sees astounding 28,859 percent revenue growth in CBD product brands Company tapping into economic potential of huge ethnic Chinese population in China and North America Company delivers education and analysis in Chinese on all aspects of cryptocurrency production and trade A financial information company dedicated to empowering Chinese-speaking investors and building on the market potential of cannabis-infused health and wellness products is announcing the expansion of its footprint in North America with the opening of offices in eastern Canada. ChineseInvestors.com, Inc. (OTCQB: CIIX) issued a news release on September 17 stating that it now has a sales and support…

FridaySep 21, 2018 11:26 am

Earth Science Tech, Inc. (ETST) Sees Uplisting to OTCQB Venture Market as Key to Goal of being Global Leader in Cannabinoid Market

Biotech company is focused on becoming a worldwide leader in R&D and sale of hemp-derived, CBD-based nutraceuticals, pharmaceuticals and dietary supplements ETST is developing three new CBD formulas in Canada under a provisory patent; it is also clinical testing its Hygee medical device for detecting sexually transmitted diseases in women With its Form 10 Registration Statement filing now effective, ETST will begin reporting annual, quarterly and periodic financial statements Earth Science Tech, Inc. (OTCQB: ETST) anticipates that its uplisting to the OTCQB Venture Market will enable it to reach global recognition and increase liquidity as a leader in the hemp-based…

FridaySep 21, 2018 11:23 am

Will Canopy Growth’s Spin-Off Canopy Rivers Be A Powerful Growth Engine?

Canopy Growth will reduce exposure to dilution and debt with the investment model of the new company. The business model of Canopy Rivers has one major flaw. The way Canopy Rivers must be analyzed in order to understand its growth potential. Canopy Growth (NYSE: CGC) is near to spinning off its new financial investment company called Canopy Rivers into a publicly traded firm, which will pursue investment opportunities in the growing cannabis sector. With a business model that has done extremely well for companies in other markets, if it is able to successfully leverage the model, Canopy Rivers has the…

ThursdaySep 20, 2018 12:00 pm

Youngevity International, Inc. (NASDAQ: YGYI) Coffee Business Takes to the High Seas, Boosts Profits

Two-year contract brings company’s CLR Roasters coffee brand to patrons, crews of international cruise line YGYI CEO appointed to board of directors of Direct Selling Association, a national trade organization representing direct selling industry Q1 2018 revenues rose by 11 percent over Q1 2017 at $43 million, with gross profits increasing to $25 million YGYI enters $7.7 billion cannabis market with HempFX product line Leading omni-direct lifestyle company Youngevity International, Inc. (NASDAQ: YGYI) is making enviable strides among several sectors of the direct selling industry as it expands its brands and offerings in multiple markets. Among the latest highlights is…

News and publishing service for CBD related companies

Contact us: 512.354.7000